DE68905119D1 - Methode zur kontrolle von pneumocystis carinii. - Google Patents

Methode zur kontrolle von pneumocystis carinii.

Info

Publication number
DE68905119D1
DE68905119D1 DE8989309257T DE68905119T DE68905119D1 DE 68905119 D1 DE68905119 D1 DE 68905119D1 DE 8989309257 T DE8989309257 T DE 8989309257T DE 68905119 T DE68905119 T DE 68905119T DE 68905119 D1 DE68905119 D1 DE 68905119D1
Authority
DE
Germany
Prior art keywords
pneumocystis carinii
controlling
controlling pneumocystis
carinii
pneumocystis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8989309257T
Other languages
English (en)
Other versions
DE68905119T2 (de
Inventor
Dennis M Schmatz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of DE68905119D1 publication Critical patent/DE68905119D1/de
Publication of DE68905119T2 publication Critical patent/DE68905119T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8989309257T 1988-09-12 1989-09-12 Methode zur kontrolle von pneumocystis carinii. Expired - Lifetime DE68905119T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24276788A 1988-09-12 1988-09-12
US24604288A 1988-09-16 1988-09-16
US39888989A 1989-08-30 1989-08-30

Publications (2)

Publication Number Publication Date
DE68905119D1 true DE68905119D1 (de) 1993-04-08
DE68905119T2 DE68905119T2 (de) 1993-08-26

Family

ID=27399603

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989309257T Expired - Lifetime DE68905119T2 (de) 1988-09-12 1989-09-12 Methode zur kontrolle von pneumocystis carinii.

Country Status (7)

Country Link
EP (1) EP0359529B1 (de)
JP (1) JPH0725692B2 (de)
CA (1) CA1333150C (de)
DE (1) DE68905119T2 (de)
DK (1) DK173802B1 (de)
ES (1) ES2054017T3 (de)
IE (1) IE892924L (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2020063A1 (en) * 1989-06-30 1990-12-31 Robert A. Giacobbe Antibiotic agent
GB8925593D0 (en) * 1989-11-13 1990-01-04 Fujisawa Pharmaceutical Co Fr901379 substance and preparation thereof
GB2241956A (en) * 1990-03-16 1991-09-18 Merck & Co Inc N-acylated cyclohexapeptide compounds
US5021403A (en) * 1990-03-19 1991-06-04 Merck & Co., Inc. Antibiotic agents
IL98506A (en) * 1990-06-18 1996-09-12 Fujisawa Pharmaceutical Co Peptides, of antibiotics, processes for their preparation and pharmaceutical preparations containing them
USH1638H (en) * 1990-11-08 1997-03-04 Furuta; Takahisa Use of the polypeptide compound
EP0486011A3 (en) * 1990-11-16 1992-07-15 Fujisawa Pharmaceutical Co., Ltd. Pharmaceutical composition against pneumocystis carinii
US5366880A (en) * 1990-12-19 1994-11-22 Merck & Co., Inc. Antibiotic agent
US5306708A (en) * 1990-12-19 1994-04-26 Merck & Co., Inc. Antibiotic agent
US5369093A (en) * 1991-03-15 1994-11-29 Merck & Co., Inc. Lipopeptide derivatives
TW199162B (de) * 1991-05-09 1993-02-01 Fujisawa Pharmaceutical Co
US6030944A (en) * 1991-10-01 2000-02-29 Merck & Co., Inc. Cyclohexapeptidyl bisamine compounds
US5430018A (en) * 1991-10-17 1995-07-04 Merck & Co., Inc. Cyclohexapeptide with basic nitrogen containing alkylamide groups
EP0539088B1 (de) * 1991-10-17 1996-07-17 Merck & Co. Inc. Echinocandin-B-Derivat
US5965525A (en) * 1992-03-19 1999-10-12 Eli Lilly And Company Cyclic peptide antifungal agents
US6384013B1 (en) 1992-03-19 2002-05-07 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US6743777B1 (en) 1992-03-19 2004-06-01 Eli Lilly And Company Cyclic peptide antifungal agents and process for preparation thereof
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds
GB9506372D0 (en) * 1995-03-29 1995-05-17 Fujisawa Pharmaceutical Co New peptide compounds
US5646111A (en) * 1995-04-07 1997-07-08 Eli Lilly And Company Cyclic peptide antifungal Agents
US5786325A (en) * 1995-05-26 1998-07-28 Eli Lilly And Company Cyclic peptide antifungal agents and methods of making and using
US5652213A (en) * 1995-05-26 1997-07-29 Eli Lilly And Company Cyclic peptide antifungal agents
US5618787A (en) * 1995-05-26 1997-04-08 Eli Lilly And Company Cyclic peptide antifungal agents
US5629290A (en) * 1995-05-26 1997-05-13 Eli Lilly And Company Cyclic peptide antifungal agents
WO2000011023A2 (en) 1998-08-20 2000-03-02 Eli Lilly And Company Ring modified cyclic peptide analogs
DK1137663T3 (da) 1998-12-09 2007-01-08 Lilly Co Eli Oprensning af Echinocandin-cyclopeptidforbindelser
KR20020002476A (ko) 1999-03-03 2002-01-09 피터 지. 스트링거 결정질 에키노칸딘 암모늄염의 형성 및 음이온 교환
BR0008712A (pt) 1999-03-03 2001-12-26 Lilly Co Eli Complexos equinocandina/carboidrato
CN100335122C (zh) 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂
CN1345230A (zh) 1999-03-03 2002-04-17 伊莱利利公司 口服ecb药物制剂和药物组合物的制备方法
US6991800B2 (en) 2002-06-13 2006-01-31 Vicuron Pharmaceuticals Inc. Antifungal parenteral products

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2803581A1 (de) * 1978-01-27 1979-08-02 Sandoz Ag Derivate des tetrahydro-echinocandin b
CA1183127A (en) * 1979-12-13 1985-02-26 Manuel Debono Process for the preparation of derivatives of cyclic peptide nuclei
US4968608A (en) * 1987-10-07 1990-11-06 Merck & Co., Inc. Process for antifungal fermentation product
EP0311193B1 (de) * 1987-10-07 1993-12-01 Merck & Co. Inc. Fungizides Fermentationsprodukt

Also Published As

Publication number Publication date
DK446389A (da) 1990-03-13
JPH0725692B2 (ja) 1995-03-22
DE68905119T2 (de) 1993-08-26
JPH02288837A (ja) 1990-11-28
DK173802B1 (da) 2001-11-05
EP0359529B1 (de) 1993-03-03
ES2054017T3 (es) 1994-08-01
IE892924L (en) 1990-03-12
EP0359529A1 (de) 1990-03-21
DK446389D0 (da) 1989-09-11
CA1333150C (en) 1994-11-22

Similar Documents

Publication Publication Date Title
DE68905119D1 (de) Methode zur kontrolle von pneumocystis carinii.
DE3785112T2 (de) Fahrzeug-Regelsystem und Methode dafür.
DE3771255D1 (de) Ventilsteuerungsanordnung und ventilsteuerungsverfahren.
DE3878685D1 (de) Implantat zur fixierung von wirbeln.
DE68928113D1 (de) Reihenfolgesteuersystem zur Behandlung von Befehlen
DE68909179T2 (de) Verschlusselement zur Kontrolle von Ileokolostomie.
DE69323983T2 (de) Methode zur Modifizierung des Fettdruckes von Buchstaben
DE68923419D1 (de) Methode zur Züchtung von Bakterien.
DE3750073D1 (de) Programmierbare Folgesteuerung.
DE3776090D1 (de) Verfahren zur kontrolle von warenartikeln.
DE3686130D1 (de) Geschmackskontrolle von proteinhydrolysaten.
DE3886043D1 (de) Methode und system zur bestimmung von oberflächenprofilinformationen.
DE3683590D1 (de) Ferroelektrische smektische c-mischung, verfahren zur kontrolle ihres kippwinkels und lichtschalterelement.
DE3825172A1 (de) Mittel zur bekaempfung von floehen
DE68907184D1 (de) Verfahren zur zuechtung von kristallen und tiegel dafuer.
DE3763265D1 (de) Betriebssteuersystem und -verfahren.
DE3780335T2 (de) Prozesssteuerungssystem und -verfahren.
DE3770967D1 (de) Verfahren zur beherrschung von unkraut.
DE3853253T2 (de) Verfahren und System zur Sequenzsteuerung.
DE68904050D1 (de) Methode zur kontrolle von pneumocystis carinii.
DE68912536T2 (de) Flüssiges Nahrungsmittel zur Proteinzuführung.
ATE86116T1 (de) Methode zur kontrolle von pneumocystis carinii.
DE68917536T2 (de) Methode zur Reduktion von aromatischen Amino-Gruppen.
DE3778296D1 (de) Verhinderung von biologischem bewuchs mit bestimmten alkylthioalkylaminen.
DE3688429T2 (de) Handbetaetigtes regelventil.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee